Logo image
Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes
Journal article   Open access   Peer reviewed

Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes

Ahmed Al-Badri, Zeba Hashmath, Garrett H Oldland, Rachana Miller, Khuzaima Javaid, Amer Ahmed Syed, Bilal Ansari, Swetha Gaddam, Walter R Witschey, Scott R Akers, …
Diabetes care, Vol.41(9), pp.2019-2025
09/01/2018
DOI: 10.2337/dc18-0324
PMCID: PMC6105326
PMID: 30002196
url
https://doi.org/10.2337/dc18-0324View
Published (Version of record) Open Access

Abstract

We assessed whether poor glycemic control is associated with an increase in myocardial fibrosis among adults with diabetes. We studied 47 adults with type 2 diabetes and stratified them into three groups according to their hemoglobin A1c (HbA ) level: <6.5% (group 1; = 12), 6.5-7.5% (group 2; = 20), and >7.5% (group 3; = 15). Left ventricular (LV) mass was assessed using cardiac MRI. The extracellular volume fraction (ECVF), an index of myocardial fibrosis, was measured by using myocardial T1 mapping before and after the administration of a gadolinium-based contrast agent. Mean HbA was 5.84 ± 0.16%, 6.89 ± 0.14%, and 8.57 ± 0.2% in groups 1, 2, and 3, respectively. LV mass was not significantly different between the groups. The myocardial ECVF was significantly greater in groups 2 (mean 27.6% [95% CI 24.8-30.3]) and 3 (27.6% [24.4-30.8]) than in group 1 (21.1% [17.5-24.7]; = 0.015). After adjusting for age, sex, BMI, blood pressure, and estimated glomerular filtration rate, the myocardial ECVF was significantly greater in groups 2 (27.4% [24.4-30.4]) and 3 (28% [24.5-31.5]) than in group 1 (20.9% [17.1-24.6]; = 0.0156, ANCOVA). An increased myocardial ECVF, suggesting myocardial fibrosis, is independently associated with poor glycemic control among adults with diabetes. Further research should assess whether tight glycemic control can revert fibrosis to healthy myocardium or ameliorate it and its adverse clinical consequences.
Aged Blood Glucose - metabolism Cardiomyopathies - blood Cardiomyopathies - complications Cardiomyopathies - diagnosis Cardiomyopathies - physiopathology Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - physiopathology Diabetes Mellitus, Type 2 - therapy Diabetic Cardiomyopathies - blood Diabetic Cardiomyopathies - diagnosis Diabetic Cardiomyopathies - physiopathology Female Fibrosis - blood Fibrosis - diagnosis Fibrosis - etiology Fibrosis - physiopathology Glycated Hemoglobin - analysis Glycated Hemoglobin - metabolism Humans Magnetic Resonance Imaging Male Middle Aged Myocardium - pathology Stroke Volume - physiology

Details

Metrics

Logo image